智慧吸入器市场:各产品,各流通管道,各地区-规模,占有率,展望,机会分析,2023~2030年
市场调查报告书
商品编码
1290618

智慧吸入器市场:各产品,各流通管道,各地区-规模,占有率,展望,机会分析,2023~2030年

Smart Inhalers Market, By Product ((Inhalers (Metered Dosage Inhalers and Dry Powder Inhalers and Nebulizers), By Distribution Channel, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3个工作天内

价格
简介目录

市场动态:

呼吸疾病盛行率的上升,全球老年人口的增加,全球COVID-19发生,智慧吸入器的需求/采用的增加,促进全球智慧吸入器市场成长。

本调查的主要特征

  • 本报告提供以2021年为基准年的预测期间(2022-2030 年)之全球智慧吸入器市场的市场规模和復合年增长率(CAGR %)相关的详细分析。
  • 并阐明不同部门市场的潜在收入机会,说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点,各类型投资组合、主要焦点、财务业绩和市场策略等参数,介绍全球智慧吸入器市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察,将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球智慧吸入器市场报告配合该行业的各种利益相关者,包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球智慧吸入器市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查的目的与前提条件

  • 调查的目的
  • 前提条件
  • 简称

第2章 市场展望

  • 报告概要
    • 市场定义和范围
  • 摘要整理
  • 连贯·机遇·地图(COM)

第3章 市场动态,法规,趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 影响分析
  • 主要的焦点
  • 法规情势
  • 产品销售/核准
  • PEST分析
  • 波特分析
  • 合併·收购情势

第4章 智慧吸入器的全球市场-冠状病毒(COVID-19)大流行病的影响

  • 关于COVID-19流行病学
  • 供给面和需求面的分析
  • 经济影响

第5章 智慧吸入器的全球市场,各类型,2017年~2030年

  • 吸入器
  • 定量喷雾吸入器(MDI)
  • 干粉吸入器(DPI)
  • 喷雾器

第6章 智慧吸入器的全球市场,各流通管道,2017年~2030年

  • 医院
  • 药局

第7章 智慧吸入器的全球市场,各地区,2017年~2030年

  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲地区

第8章 竞争情形

  • Adherium Limited
  • AstraZeneca
  • Boehringer Ingelheim
  • Cohero Health
  • GSK
  • Novartis
  • ResMed

第9章 章节

  • 关于调查手法
  • 关于出版社
简介目录
Product Code: CMI5738

A smart inhaler is a medical device that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use.

Market Dynamics:

Rise in prevalence of respiratory disorders, growing geriatric (aging) population around the world, the outbreak of COVID-19 across the globe, and increasing demand/adoption of smart inhalers are major factors expected to drive growth of the global smart inhalers market. For instance, In January 2023, Aseptika won an Innovate UK Smart Award to develop a Smart Inhaler Tracker for patients with lung health conditions. The Smart Award will help the company develop its third-generation smart inhaler tracker, which will have 5G mobile connectivity built-in. This means that patients will no longer have to send their data via a smartphone to their clinical teams, carers, or parent; it will just send information over the airwaves directly to the company's cloud databases.

Key features of the study:

  • This report provides in-depth analysis of the global smart inhalers market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global smart inhalers market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GSK, Novartis, and ResMed, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global smart inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smart inhalers market.

Detailed Segmentation:

  • Global Smart Inhalers Market, By Product:
    • Inhalers
    • Metered Dosage Inhalers (MDIs)
    • Dry Powder Inhalers (DPIs)
    • Nebulizers
  • Global Smart Inhalers Market, By Distribution Channel:
    • Hospitals
    • Pharmacies
  • Global Smart Inhalers Market, By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Adherium Limited
    • AstraZeneca
    • Boehringer Ingelheim
    • Cohero Health
    • GSK
    • Novartis
    • ResMed

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Distribution channel
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in prevalence of respiratory disorders
    • Lack of awareness and high cost of smart inhalers
    • Increasing demand/adoption of smart inhalers
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Smart Inhalers Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Smart Inhalers Market, By Type, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Metered Dosage Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
  • Nebulizers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Smart Inhalers Market, By Distribution channel, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Smart Inhalers Market, By Geography, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017-2030,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017-2030,(US$ Mn)

8. Competitive Landscape

  • Adherium Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cohero Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GSK
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ResMed
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us